5-METHOXY-3H-BENZO[E]INDOLE-2-CARBOXYLIC ACID
![]() |
- $45 - $500.7
- Product name: 5-METHOXY-3H-BENZO[E]INDOLE-2-CARBOXYLIC ACID
- CAS: 887360-44-3
- MF: C14H11NO3
- MW: 241.24
- EINECS:
- MDL Number:MFCD07357611
- Synonyms:5-METHOXY-3H-BENZO[E]INDOLE-2-CARBOXYLIC ACID
5 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- TRC
Package
- 5MG
- 100mg
- 250mg
- 500mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0075829
- Product description5-METHOXY-3H-BENZO[E]INDOLE-2-CARBOXYLIC ACID 95.00%
- Packaging5MG
- Price$500.7
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11030469
- Product description5-Methoxy-3h-benzo[e]indole-2-carboxylicacid 95+%
- Packaging1g
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM267093
- Product description5-Methoxy-3h-benzo[e]indole-2-carboxylicacid
- Packaging100mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM267093
- Product description5-Methoxy-3h-benzo[e]indole-2-carboxylicacid
- Packaging250mg
- Price$90
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM267093
- Product description5-Methoxy-3h-benzo[e]indole-2-carboxylicacid
- Packaging500mg
- Price$140
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0075829 | 5-METHOXY-3H-BENZO[E]INDOLE-2-CARBOXYLIC ACID 95.00% | 5MG | $500.7 | 2021-12-16 | Buy |
Crysdot | CD11030469 | 5-Methoxy-3h-benzo[e]indole-2-carboxylicacid 95+% | 1g | $452 | 2021-12-16 | Buy |
TRC | M267093 | 5-Methoxy-3h-benzo[e]indole-2-carboxylicacid | 100mg | $45 | 2021-12-16 | Buy |
TRC | M267093 | 5-Methoxy-3h-benzo[e]indole-2-carboxylicacid | 250mg | $90 | 2021-12-16 | Buy |
TRC | M267093 | 5-Methoxy-3h-benzo[e]indole-2-carboxylicacid | 500mg | $140 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|